Top 5 Logistics Companies For 2014

GasLog Partners (GLOP) is a limited partnership firm which owns, operates and acquires LNG carriers under long-term charter of five years or more. The company has an initial fleet of three LNG carriers with long-term contracts scheduled to expire in 2018 and 2019.

GasLog (GLOG) is the parent company of GasLog Partners. The company is an owner, operator and manager of LNG carriers and works as a part of LNG logistics chain. In April 2012, the company had a fleet of 10 LNG carriers and since then GasLog has increased its capacity by 111% to 21 fully owned ships.

This article discusses the investment positives for the recently listed GasLog Partners. The investment conclusion is that the company is a strong buy for the long term.

Key Investment Positives:�Modern Fleet with Visible Growth

GasLog Partners��initial fleet consists of three LNG carriers with contract expiry in 2018 and 2019. In addition to this, GasLog Partners has the option to purchase 12 LNG carriers over the next three years.

Top 5 Biotech Stocks To Invest In Right Now: Silver Spruce Resources Inc (SSE)

Silver Spruce Resources Inc. is a junior exploration company. The Company�� operations consist of the exploration for precious and base minerals with a focus on uranium, mainly in the Central Mineral Belt of Labrador, which include Popes Hill, the Popes Hill JV with Great Western Minerals Group, and the MRT, RWM and Straits properties. The Company�� projects include Double Mer Property, Mount Benedict Property, Big Easy Property, MRT Property, Pope�� Hill area, Red Wine Mountains and Straits Property. The Snegamook Lake property is located just to the southeast of Snegamook Lake in central Labrador, in the western part of the Central Mineral Belt (CMB), consists of 86 claims. The Fishhawk lake is located to the southeast of Snegamook Lake in central Labrador, in the western part of the CMB, consists of 164 claims. On August 22, 2012, the Company purchased a uranium exploration property in the CMB of Labrador from Virginia Energy Resources Inc. Advisors' Opinion:

• [By Namitha Jagadeesh]

  SSE Plc (SSE) slid 5.8 percent to 1,489 pence as Citigroup said in a note that the supplier of gas and electricity would suffer the most from price caps or other forms of government intervention because it gets 97 percent of revenue from the U.K.

Top 5 Logistics Companies For 2014: Ralcorp Holdings Inc.(RAH)

Ralcorp Holdings, Inc. engages in manufacturing, distributing, and marketing private-brand food products, ready-to-eat cereal products, and other regional and value-brand food products. Its products include ready-to-eat and hot cereals; nutritional and cereal bars; snack mixes, corn-based chips, and extruded corn snack products; crackers and cookies; snack nuts; chocolate candy; salad dressings; mayonnaise; peanut butter; jams and jellies; syrups; sauces; frozen griddle products, including pancakes, waffles, and French toast; frozen biscuits and other frozen pre-baked products, such as breads and rolls; frozen and refrigerated doughs; and dry pasta. The company offers its products under various brands, including Post, Honey Bunches of Oats, Pebbles, Post Selects, Great Grains, Spoon Size, Grape-Nuts, Honeycomb, 3 Minute Brand, Ralston, Parco, Lofthouse, Krusteaz, Panne Provincio, Major Peters?, Medallion, Ry Krisp, Champagne, Monet, Rippin? Good, Hoody?s, Linette, JERO, Flavor House, Nutcracker, Pennsylvania Dutch, Heartland, Golden Grain, Anthony?s, Pasta Lensi, Ronco, and Mueller?s. It also develops, manufactures, and markets emulations of various types of branded food products to retailers, mass merchandisers, and drug stores to sell under their own store brands or under value-brands. Ralcorp Holdings, Inc. sells its products to retail chains, mass merchandisers, grocery wholesalers, warehouse club stores, drugstores, restaurant chains, and foodservice distributors in the United States, as well as in Canada, Europe, and southeast Asia. It offers its products through a broker network, internal sales staff, independent sales agency, a network of third party warehouses, and independent truck lines. The company was founded in 1995 and is based in St. Louis, Missouri.

Advisors' Opinion:

• [By Louis Navellier]

  A $15.5 billion business that employs 34,800 worldwide, ConAgra is the fourth largest player in the Processed & Packaged Goods industry. In early 2013, ConAgra completed its buyout of Ralcorp Holdings (RAH) making the combined company one of the largest packaged food players on the continent.

Top 5 Logistics Companies For 2014: InfoSonics Corp(IFON)

InfoSonics Corporation engages in the design, development, sourcing, and sale of wireless handsets and accessories in Latin America and the Asia Pacific. The company offers a line of entry-level, mid-tier, and high-end products under the verykool brand name. It contracts with electronic manufacturing services providers to manufacture its branded products. The company?s customers include carriers, agents, distributors, resellers, and original equipment manufacturers. InfoSonics Corporation was founded in 1994 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Bryan Murphy]

  Looking for some new trading ideas? Start by putting Arrowhead Research Corp. (NASDAQ:ARWR) and InfoSonics Corporation (NASDAQ:IFON) on your watchlist... though not yet in your portfolio. Though both IFON and ARWR have laid the foundation for a rally, neither has gotten above their final humps. Here's a closer look at what it's going to take.

Top 5 Logistics Companies For 2014: EnteroMedics Inc.(ETRM)

EnteroMedics Inc., a clinical development stage medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity and associated co-morbidities, and other gastrointestinal disorders. The company?s proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. Its product under development is the Maestro System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. The company intends to market its products to potential referral source clinicians, including general practitioners, internists, endocrinologists, and nurses. It has collaboration agreement with Mayo Clinic and Australian Institute of Weight Control. The company was formerly known as Beta Medical, Inc. and changed its name to EnteroMedics Inc. in 2003 . EnteroMedics Inc. was founded in 2002 and is headquartered in St. Paul, Minnesota.

Advisors' Opinion:

• [By Roberto Pedone]

  One under-$10 health care player that's starting to trend within range of triggering a big breakout trade is EnteroMedics (ETRM), which is engaged in design and development of devices that use neuroblocking technology to treat obesity, its associated co-morbidities and other gastrointestinal disorders. This stock has been hit hard by the sellers so far in 2013, with shares off sharply by 59%.

  If you take a look at the chart for EnteroMedics, you'll notice that this stock recently formed a double bottom chart pattern $1 to $1.01 a share. Following that bottom, shares of ETRM have started to rip higher and trend back above its 50-day moving average at $1.08 a share with strong upside volume flows. This move is quickly pushing ETRM within range of triggering a big near-term breakout trade.

  Traders should now look for long-biased trades in ETRM if it manages to break out above some near-term overhead resistances levels at $1.14 to $1.19 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 584,986 shares. If that breakout triggers soon, then ETRM will set up to re-test or possibly take out its next major overhead resistance levels at $1.37 to $1.47 a share. Any high-volume move above those levels will then give ETRM a chance to re-fill some of its previous gap down zone from February that started above $3 a share.

  Traders can look to buy ETRM off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average of $1.08 a share, or below more key near-term support at $1 a share. One can also buy ETRM off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By John Udovich]

  Small cap biotech Arena Pharmaceuticals, Inc (NASDAQ: ARNA) soared yesterday and last Friday on earnings as well as news that the company will expand its marketing and supply agreement with Japan based Eisai for its BELVIQ (lorcaserin HCl) obesity drug, meaning it might be time to take a closer look at other biotech stocks like Orexigen Therapeutics, Inc (NASDAQ: OREX), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS) that are in the business of treating obesity. Specifically, Arena Pharmaceuticals announced an expanded agreement providing Eisai with exclusive commercialization rights for all countries worldwide (except for South Korea, Taiwan, Australia, Israel and New Zealand) for BELVIQ where Arena will receive an upfront payment of $60 million and is eligible to receive up to a total of $176.5 million in regulatory and development milestone payments - an increase of $123 million from the amount remaining available under the previous agreement. BELVIQ was approved in June 2012, but didn't reach the market until June 2013 due to logistical concerns like classification by the Drug Enforcement Administration. Its also�approved for use in adults who are obese or who are overweight and who have at least one serious medical condition (e.g. diabetes or high cholesterol).

• [By John Udovich]

  Orexigen Therapeutics, Inc (NASDAQ: OREX), like Arena Pharmaceuticals, Inc (NASDAQ: ARNA), EnteroMedics Inc (NASDAQ: ETRM) and VIVUS, Inc (NASDAQ: VVUS), is a speculative small cap obesity drug stock that has the potential for coming up with the next big thing in the treatment of obesity that is increasingly a global problems. I should mention that we have recently added Orexigen Therapeutics to our SmallCap Network Elite Opportunity (SCN EO) portfolio as an extremely speculative biotech bet because its�lead obesity drug candidate has the potential to be�approved by September 11th of this year.

• [By James E. Brumley]

  Look out VIVUS, Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA). There's a new weight-loss player ready to take aim at your target market, and its name is EnteroMedics Inc. (NASDAQ:ETRM). If the recent action from ETRM is any indication, the market thinks it could be a real threat to your weight-loss ventures.